No More Venous Ulcers-What More Can We Do?

Area of Science:

• Vascular Medicine
• Dermatology
• Public Health

Background:

• Venous leg ulcers (VLUs) are the most severe complication of chronic venous insufficiency, accounting for 70-90% of chronic leg ulcers.
• Approximately 1% of the Western population experiences VLUs, characterized by poor healing and high recurrence rates.
• VLUs impose a substantial socioeconomic burden, impacting quality of life and healthcare expenditure.

Purpose of the Study:

• To provide a comprehensive review of venous leg ulcers (VLUs).
• To discuss epidemiology, socioeconomic impact, pathophysiology, diagnosis, and treatment options for VLUs.
• To highlight the importance of early detection and preventive measures for chronic venous disease to reduce VLU incidence.

Main Methods:

• Literature review of epidemiology, pathophysiology, diagnosis, and treatment of VLUs.
• Analysis of socioeconomic burden and quality of life impacts associated with VLUs.
• Discussion of current and future strategies for VLU prevention.

Main Results:

• VLUs are a major complication of chronic venous insufficiency with significant recurrence rates.
• The economic impact of VLU treatment is substantial, estimated at 3% of total healthcare expenditure.
• Current knowledge gaps in pathophysiology and treatment protocols present challenges in achieving a VLU-free state.

Conclusions:

• Reducing VLU incidence requires early identification of high-risk patients with chronic venous disease.
• Implementing appropriate preventive measures is crucial for managing and decreasing the burden of VLUs.
• Further research into pathophysiology and therapeutic protocols is needed to improve VLU outcomes.